SP Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.55M | Sell |
2,770
-70
| -2% | -$71K | 0.22% | 54 |
|
|
2025
Q4 | $3.05M | Buy |
2,840
+4
| +0.1% | +$3.83K | 0.24% | 58 |
|
|
2025
Q3 | $2.16M | Buy |
2,836
+2
| +0.1% | +$1.49K | 0.17% | 66 |
|
|
2025
Q2 | $2.21M | Buy |
2,834
+9
| +0.3% | +$6.99K | 0.18% | 66 |
|
|
2025
Q1 | $2.33M | Buy |
2,825
+7
| +0.2% | +$5.83K | 0.21% | 62 |
|
|
2024
Q4 | $2.18M | Buy |
2,818
+4
| +0.1% | +$3.31K | 0.18% | 68 |
|
|
2024
Q3 | $2.49M | Buy |
2,814
+4
| +0.1% | +$3.6K | 0.21% | 59 |
|
|
2024
Q2 | $2.54M | Buy |
2,810
+107
| +4% | +$85.6K | 0.23% | 60 |
|
|
2024
Q1 | $2.1M | Buy |
2,703
+4
| +0.1% | +$2.85K | 0.2% | 62 |
|
|
2023
Q4 | $1.57M | Buy |
2,699
+5
| +0.2% | +$2.92K | 0.16% | 66 |
|
|
2023
Q3 | $1.45M | Buy |
2,694
+304
| +13% | +$157K | 0.16% | 67 |
|
|
2023
Q2 | $1.12M | Buy |
2,390
+23
| +1% | +$9.65K | 0.13% | 70 |
|
|
2023
Q1 | $813K | Buy |
2,367
+9
| +0.4% | +$3.04K | 0.1% | 76 |
|
|
2022
Q4 | $863K | Buy |
2,358
+6
| +0.3% | +$2.13K | 0.12% | 74 |
|
|
2022
Q3 | $761K | Buy |
2,352
+7
| +0.3% | +$2.22K | 0.1% | 75 |
|
|
2022
Q2 | $760K | Buy |
2,345
+8
| +0.3% | +$2.4K | 0.1% | 77 |
|
|
2022
Q1 | $669K | Buy |
2,337
+8
| +0.3% | +$2.06K | 0.07% | 88 |
|
|
2021
Q4 | $578K | Buy |
2,329
+9
| +0.4% | +$2.28K | 0.06% | 88 |
|
|
2021
Q3 | $581K | Buy |
2,320
+7
| +0.3% | +$1.73K | 0.06% | 86 |
|
|
2021
Q2 | $563K | Buy |
2,313
+9
| +0.4% | +$1.81K | 0.06% | 82 |
|
|
2021
Q1 | $434K | Buy |
2,304
+10
| +0.4% | +$1.96K | 0.05% | 83 |
|
|
2020
Q4 | $463K | Buy |
2,294
+11
| +0.5% | +$1.64K | 0.06% | 79 |
|
|
2020
Q3 | $332K | Buy |
2,283
+11
| +0.5% | +$1.7K | 0.05% | 77 |
|
|
2020
Q2 | $373K | Buy |
2,272
+11
| +0.5% | +$1.69K | 0.08% | 67 |
|
|
2020
Q1 | $314K | Buy |
2,261
+12
| +0.5% | +$1.65K | 0.09% | 64 |
|
|
2019
Q4 | $296K | Buy |
2,249
+12
| +0.5% | +$1.39K | 0.07% | 68 |
|
|
2019
Q3 | $250K | Buy |
+2,237
| New | +$249K | 0.06% | 71 |
|
|
2019
Q2 | – | Sell |
-2,212
| Closed | -$287K | – | 78 |
|
|
2019
Q1 | $287K | Buy |
2,212
+11
| +0.5% | +$1.34K | 0.08% | 62 |
|
|
2018
Q4 | $254K | Buy |
2,201
+11
| +0.5% | +$1.23K | 0.08% | 64 |
|
|
2018
Q3 | $235K | Buy |
+2,190
| New | +$219K | 0.07% | 69 |
|
Other funds holding LLY
VCM
VPM
SP Asset Management's LLY Position: Q1 2026 in Review
SP Asset Management reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $71K and leaving 2,770 shares worth $2.55M. The position accounts for 0.22% of the portfolio, ranked #54.
SP Asset Management first reported a position in LLY in Q3 2018 and has held it in 30 quarters since. The position peaked at $3.05M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- SP Asset Management held 2,770 shares of Eli Lilly worth $2.55M as of Q1 2026.
- SP Asset Management sold 70 Eli Lilly shares in Q1 2026, an estimated $71K.
- Eli Lilly made up 0.22% of SP Asset Management's portfolio in Q1 2026, its #54 holding.
- SP Asset Management first reported a position in Eli Lilly in Q3 2018 and has held it in 30 quarters since.
- SP Asset Management's Eli Lilly position peaked at $3.05M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on SP Asset Management's 13F filing for Q1 2026, filed 7 May 2026.